Ritonavir Enrolling by Invitation Phase 4 Trials for Novel Coronavirus Infectious Disease (COVID-19) Treatment

IndicationsStatusPurposePhase
Enrolling by InvitationTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT04350671Interferon Beta 1a in Hospitalized COVID-19 Patients
NCT04350684Umifenovir in Hospitalized COVID-19 Patients